Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06772779 · ClinicalTrials.gov registry record · Phase 1
A Study of Enlicitide Decanoate (MK-0616), Warfarin, and Lisinopril in Healthy Adult Participants (MK-0616-026)
A Phase 1 study, sponsored by Merck Sharp & Dohme.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT06772779 is a Phase 1 study that has completed, run by Merck Sharp & Dohme. The registered enrollment target is 36 participants.
The verdict
NCT06772779, a Phase 1 study, has completed, sponsored by Merck Sharp & Dohme.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
The main goal of this study is to learn what happens in a person's body over time when they take enlicitide decanoate with warfarin or lisinopril. Researchers want to learn if the amount of warfarin in a person's blood is similar when warfarin is taken alone or with enlicitide decanoate. Enlicitide decanoate is a new medicine that lowers the amount of cholesterol in a person's blood. Warfarin is a drug that reduces risk of blood clotting, and lisinopril is a drug that lowers blood pressure.
Interventions
- DRUG Warfarin
- DRUG Enlicitide Decanoate
- DRUG Lisinopril
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2024-06-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06772779
The ClinicalTrials.gov registry entry for NCT06772779 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merck Sharp & Dohme, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Warfarin is the first listed.
NCT06772779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06772779 about?
NCT06772779 is a clinical study titled "A Study of Enlicitide Decanoate (MK-0616), Warfarin, and Lisinopril in Healthy Adult Participants (MK-0616-026)". The main goal of this study is to learn what happens in a person's body over time when they take enlicitide decanoate with warfarin or lisinopril. Researchers want to learn if the amount of warfarin in a person's blood is similar when warfarin is taken alone or with enlicitide decanoate. Enlicitide...
What is the current status of trial NCT06772779?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2024-04-01. Estimated completion is 2024-06-04.
What interventions are being tested in trial NCT06772779?
The interventions under investigation include: Warfarin (DRUG), Enlicitide Decanoate (DRUG), Lisinopril (DRUG).
Who is sponsoring clinical trial NCT06772779?
This trial is sponsored by Merck Sharp & Dohme, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.